Core Insights - The company, Yimai Sunshine (02522.HK), announced that its subsidiary, Tianjin Yimai Yingrun Medical Imaging Diagnosis Co., Ltd., has successfully won the bid for the "Tianjin Beichen Hospital Medical Project," marking a significant step in its strategy of regional deepening and national radiation [1][2] Group 1 - The project is expected to generate annual revenue of tens of millions, indicating substantial progress in the company's strategy [1] - The project will establish a regional smart medical sharing platform, focusing on five key modules: regional imaging sharing center, smart integrated laboratory, digital pathology center, health management center, and nuclear medicine center [1] - The Beichen Hospital, established in 1963, is a comprehensive hospital with a strong foundation in various specialties, enhancing the project's credibility and potential impact [1] Group 2 - The project represents the company's first comprehensive integration project covering imaging, testing, pathology, nuclear medicine, and health management, showcasing its capabilities in regional medical resource collaboration and smart operations [2] - The implementation of this project will strengthen the company's market presence in the North China region and lay a solid foundation for promoting similar projects in the Beijing-Tianjin-Hebei area [2] - The project is expected to have positive strategic value for the company's long-term development [2]

Group 1 - The core point of the article highlights the stock performance of Kingmed Diagnostics, which closed at 30.73 yuan on August 5, showing a slight decline of 0.09 yuan or 0.29% from the previous trading day [1] - On August 5, the stock opened at 30.85 yuan, reached a high of 31.38 yuan, and a low of 30.40 yuan, with an overall trading range of 3.18% and a trading volume of 84,190 hands, amounting to 260 million yuan [1] - Kingmed Diagnostics is a leading third-party medical testing institution in China, with its main business covering medical testing, pathological diagnosis, and research services, supported by a nationwide service network [1] Group 2 - At 13:01 on August 5, Kingmed Diagnostics experienced a rapid rebound, with a price increase of over 2% within 5 minutes, rising from 30.96 yuan to 31.21 yuan, with a transaction volume of 165 million yuan during that period [1] - Despite a net outflow of 7.02 million yuan in main funds by the end of the trading day, there was a cumulative net inflow of 53.83 million yuan over the past five trading days [1]